• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(15,16-3H)纳曲酮在大鼠中枢神经系统中的分布

Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.

作者信息

Misra A L, Bloch R, Vardy J, Mulé S J, Verebely K

出版信息

Drug Metab Dispos. 1976 May-Jun;4(3):276-80.

PMID:6233
Abstract

After injection of (15,16-3H)naltrexone (10 mg/kg s.c.) in male Wistar rats, peak concentrations of drug occurred in brain and plasma within 0.5 hr. Levels of naltrexone were sustained in brain between 2 and 24 hr and were barely detectable at 48 hr. Significant amounts of metabolities were present in brain and plasma at longer time periods. The t1/2 of naltrexone in brain and plasma were approximately 8.0 and 11.4 hr. respectively. The brain/plasma ratios of naltrexone at earlier times (0.5-1 hr) were higher than those at later times. The binding of naltrexone in vitro with rat plasma proteins in concentrations of 1-10 mug/ml ranged between 41 and 59% 6beta-Naltrexol was present in very small amounts in brain but not in plasma. In addition to 7,8-dihydro-14-hydroxynormophinone and 7,8-dihydro-14-hydroxynormophine, tentative evidence was obtained for three other metabolites of naltrexone in brain. These metabolites were also present in plasma in addition to free and conjugated naltrexone and its N-dealkylated metabolites.

摘要

给雄性Wistar大鼠皮下注射(15,16 - 3H)纳曲酮(10毫克/千克)后,药物在0.5小时内于脑和血浆中达到峰值浓度。纳曲酮水平在脑内2至24小时维持稳定,48小时时几乎检测不到。较长时间段后,脑和血浆中存在大量代谢物。纳曲酮在脑和血浆中的半衰期分别约为8.0小时和11.4小时。早期(0.5 - 1小时)纳曲酮的脑/血浆比值高于后期。纳曲酮在体外与浓度为1 - 10微克/毫升的大鼠血浆蛋白的结合率在41%至59%之间。6β-纳曲醇在脑中含量极少,但在血浆中未检测到。除了7,8 - 二氢 - 14 - 羟基去甲吗啡酮和7,8 - 二氢 - 14 - 羟基吗啡外,在脑中还初步获得了纳曲酮的其他三种代谢物的证据。除了游离和结合的纳曲酮及其N - 脱烷基代谢物外,这些代谢物也存在于血浆中。

相似文献

1
Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.(15,16-3H)纳曲酮在大鼠中枢神经系统中的分布
Drug Metab Dispos. 1976 May-Jun;4(3):276-80.
2
Physiological disposition and biotransformation of [allyl-1', 3' - 14C naloxone in the rat and some comparative observations on nalorphine.大鼠体内[烯丙基-1', 3'-14C]纳洛酮的生理处置及生物转化与纳洛芬的一些比较观察
J Pharmacol Exp Ther. 1976 Feb;196(2):257-68.
3
The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.纳曲酮在兔体内的精液排泄、血浆消除、组织分布及代谢
J Pharmacol Exp Ther. 1980 May;213(2):289-99.
4
The metabolism of naltrexone in man.
NIDA Res Monogr. 1981;28:105-31.
5
Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.纳曲酮的代谢还原。I. 纳洛酮和纳曲酮还原产物的合成、分离与表征以及在给予纳曲酮、α-纳曲醇或β-纳曲醇后尿液和胆汁的定性分析。
Res Commun Chem Pathol Pharmacol. 1975 Sep;12(1):43-65.
6
The urinary excretion profiles of naltrexone in man, monkey, rabbit, and rat.
Drug Metab Dispos. 1976 Sep-Oct;4(5):474-8.
7
The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics.
NIDA Res Monogr. 1981;28:147-58.
8
Metabolism and disposition of naltrexone in man after oral and intravenous administration.
Drug Metab Dispos. 1981 Jul-Aug;9(4):369-75.
9
Naltrexone disposition in man after subcutaneous administration.皮下注射后纳曲酮在人体内的处置情况。
Drug Metab Dispos. 1984 Nov-Dec;12(6):677-82.
10
Physiological disposition and biotransformation of (3H) cocaine in acutely and chronically treated rats.(3H)可卡因在急性和慢性处理大鼠体内的生理分布及生物转化
J Pharmacol Exp Ther. 1976 Mar;196(3):556-69.

引用本文的文献

1
The Pharmacokinetics of Subcutaneous Methylnaltrexone Bromide in Rhesus Macaques ().皮下注射美沙酮溴化物在恒河猴中的药代动力学()。
J Am Assoc Lab Anim Sci. 2023 May 1;62(3):260-266. doi: 10.30802/AALAS-JAALAS-22-000111. Epub 2023 Apr 20.
2
Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and β-Endorphin.低剂量纳曲酮的益处似乎与涉及前阿黑皮素原神经元和β-内啡肽的内源性阿片系统无关。
eNeuro. 2021 Jun 16;8(3). doi: 10.1523/ENEURO.0087-21.2021. Print 2021 May-Jun.
3
Naltrexone Maintenance: Effect on Morphine Sensitivity in Normal Volunteers.
纳曲酮维持治疗:对正常志愿者吗啡敏感性的影响。
Am J Addict. 1993;2(1):34-38.
4
The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models.托吡酯和纳曲酮低剂量联合治疗对大鼠模型中乙醇强化和消耗的疗效。
Pharmacol Biochem Behav. 2014 Jan;116:107-15. doi: 10.1016/j.pbb.2013.11.013. Epub 2013 Nov 16.
5
Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.给大鼠施用的母体持续释放型纳曲酮会影响其后代成年后的神经化学和行为。
PLoS One. 2012;7(12):e52812. doi: 10.1371/journal.pone.0052812. Epub 2012 Dec 26.
6
The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.美沙酮、丁丙诺啡和纳曲酮对母婴的影响:人类和动物数据综述。
Curr Neuropharmacol. 2008 Jun;6(2):125-50. doi: 10.2174/157015908784533842.
7
A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats.一种新型δ阿片受体拮抗剂SoRI-9409可使重度饮酒大鼠的乙醇摄入量产生选择性且持久的减少。
Biol Psychiatry. 2008 Dec 1;64(11):974-81. doi: 10.1016/j.biopsych.2008.07.018. Epub 2008 Sep 6.
8
Comparison of naltrexone, 6alpha-naltrexol, and 6beta-naltrexol in morphine-dependent and in nondependent rhesus monkeys.纳曲酮、6α-纳曲醇和6β-纳曲醇在吗啡依赖和非依赖恒河猴中的比较。
Psychopharmacology (Berl). 2008 Jan;195(4):479-86. doi: 10.1007/s00213-007-0914-9. Epub 2007 Sep 16.
9
Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens.纳曲酮对乙醇强化行为的抑制作用与乙醇诱导的伏隔核透析液多巴胺水平升高的减弱有关。
J Neurosci. 1998 Dec 15;18(24):10663-71. doi: 10.1523/JNEUROSCI.18-24-10663.1998.
10
Clinical pharmacokinetics of narcotic agonist-antagonist drugs.麻醉性激动剂-拮抗剂药物的临床药代动力学。
Clin Pharmacokinet. 1983 Jul-Aug;8(4):332-43. doi: 10.2165/00003088-198308040-00004.